Nicolas Fischer

Chief Executive Officer at Berta Holding AG

58 year

Consumer Services

Distribution Services

Health Technology

Profile

Nicolas Fischer is currently the Chief Executive Officer & Director at Coty Brasil Comércio SA and the Managing Director at Berta Holding AG.
He obtained an undergraduate degree from Technische Universität Bergakademie Freiberg.

Nicolas Fischer active positions

Companies	Position	Start
Berta Holding AG Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland.	Chief Executive Officer	-
Coty Brasil Comércio SA Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil.	Chief Executive Officer	-

All active positions of Nicolas Fischer

Training of Nicolas Fischer

Technische Universität Bergakademie Freiberg

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicolas Fischer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Coty Brasil Comércio SA Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil.	Distribution Services
Berta Holding AG Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland.	Health Technology